Published in Drug Alcohol Depend on August 31, 2011
Attention-deficit/hyperactivity disorder and risk of substance use disorder: developmental considerations, potential pathways, and opportunities for research. Annu Rev Clin Psychol (2014) 1.15
Attention-deficit/hyperactivity disorder in adolescence predicts onset of major depressive disorder through early adulthood. Depress Anxiety (2013) 0.88
Risk factors for incident major depressive disorder in children and adolescents with attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry (2014) 0.78
Sequenced versus coordinated treatment for adolescents with comorbid depressive and substance use disorders. J Consult Clin Psychol (2014) 0.77
Effect of depressive symptoms on asthma intervention in urban teens. Ann Allergy Asthma Immunol (2012) 0.77
Neurobiology of hedonic tone: the relationship between treatment-resistant depression, attention-deficit hyperactivity disorder, and substance abuse. Neuropsychiatr Dis Treat (2016) 0.75
The efficacy of two adolescent substance abuse treatments and the impact of comorbid depression: results of a small randomized controlled trial. Psychiatr Rehabil J (2015) 0.75
Treatment of Adolescent Substance Use Disorders and Co-Occurring Internalizing Disorders: A Critical Review and Proposed Model. Curr Drug Abuse Rev (2015) 0.75
Measurement of drinking behavior using the Form 90 family of instruments. J Stud Alcohol Suppl (1994) 6.37
Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis. JAMA (2004) 4.12
Treatment outcomes for adolescent substance abuse at 4- and 7-month assessments. J Consult Clin Psychol (2001) 4.03
The reliability of the CIDI-SAM: a comprehensive substance abuse interview. Br J Addict (1989) 3.32
Prevalence and comorbidity of major internalizing and externalizing problems among adolescents and adults presenting to substance abuse treatment. J Subst Abuse Treat (2007) 2.41
Drug treatment outcomes for adolescents with comorbid mental and substance use disorders. J Nerv Ment Dis (2001) 2.21
Validity of structured clinical evaluations in adolescents with conduct and substance problems. J Am Acad Child Adolesc Psychiatry (2001) 1.82
Psychiatric comorbidity with problematic alcohol use in high school students. J Am Acad Child Adolesc Psychiatry (1996) 1.81
Cognitive-behavioral treatment for depression in alcoholism. J Consult Clin Psychol (1997) 1.70
A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders. Arch Pediatr Adolesc Med (2007) 1.62
Patterns of affective comorbidity in a clinical population of dually diagnosed adolescent substance abusers. J Am Acad Child Adolesc Psychiatry (1992) 1.44
Dual diagnosis and successful participation of adolescents in substance abuse treatment. J Subst Abuse Treat (2001) 1.42
Impact of psychiatric comorbidity on treatment of adolescent drug abusers. J Subst Abuse Treat (2004) 1.38
Substance-dependent, conduct-disordered adolescent males: severity of diagnosis predicts 2-year outcome. Drug Alcohol Depend (1998) 1.34
Treatment effectiveness score as an outcome measure in clinical trials. NIDA Res Monogr (1997) 1.29
Psychostimulants for depression. Cochrane Database Syst Rev (2008) 1.28
Influences on adolescent substance dependence: conduct disorder, depression, attention deficit hyperactivity disorder, and gender. Drug Alcohol Depend (1997) 1.27
Double-blind placebo-controlled trial of fluoxetine in adolescents with comorbid major depression and an alcohol use disorder. Addict Behav (2009) 1.26
Superior efficacy of cognitive-behavioral therapy for urban crack cocaine abusers: main and matching effects. J Consult Clin Psychol (1998) 1.26
Depression in substance-dependent delinquents. J Am Acad Child Adolesc Psychiatry (1995) 1.19
Relationship between use of psychiatric services and five-year alcohol and drug treatment outcomes. Psychiatr Serv (2005) 1.18
Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms. J Am Acad Child Adolesc Psychiatry (2005) 1.17
Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults. Drug Alcohol Depend (2010) 1.13
Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders. J Am Acad Child Adolesc Psychiatry (2011) 1.10
Depressive illness among chemically dependent adolescents. Am J Psychiatry (1992) 1.07
Effectiveness of dual focus mutual aid for co-occurring substance use and mental health disorders: a review and synthesis of the "Double Trouble" in Recovery evaluation. Subst Use Misuse (2008) 1.04
Behavioral therapies for co-occurring substance use and mood disorders. Biol Psychiatry (2004) 0.97
A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol (2000) 0.96
Comparison between treatment completers and noncompleters among dually diagnosed substance-abusing adolescents. J Am Acad Child Adolesc Psychiatry (1992) 0.92
Predictors of outcome in drug treatment of adolescent inpatients. Psychol Rep (1998) 0.91
Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment. Aust N Z J Psychiatry (2007) 0.89
Neurobiological and psychosocial processes associated with depressive and substance-related disorders in adolescents. Curr Drug Abuse Rev (2008) 0.88
Pemoline treatment of adolescents with attention deficit hyperactivity disorder: a short-term controlled trial. J Child Adolesc Psychopharmacol (2000) 0.87
Hospital-based adolescent substance abuse treatment: comorbidity, outcomes, and gender. J Nerv Ment Dis (2001) 0.87
Clinical correlates of obsessive compulsive disorder in children and adolescents referred to specialized and non-specialized clinical settings. Depress Anxiety (2000) 0.86
Management of the adolescent with substance use disorders and comorbid psychopathology. Child Adolesc Psychiatr Clin N Am (2010) 0.84
The care transitions intervention: results of a randomized controlled trial. Arch Intern Med (2006) 12.21
Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: a multisite effectiveness study. Drug Alcohol Depend (2005) 4.65
White matter development during childhood and adolescence: a cross-sectional diffusion tensor imaging study. Cereb Cortex (2005) 4.07
Preparing patients and caregivers to participate in care delivered across settings: the Care Transitions Intervention. J Am Geriatr Soc (2004) 3.02
Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience. Am J Addict (2004) 2.85
Factors associated with methadone maintenance treatment retention among street-recruited injection drug users. Drug Alcohol Depend (2004) 1.85
Progression of tremor and ataxia in male carriers of the FMR1 premutation. Mov Disord (2007) 1.77
Further application of the care transitions intervention: results of a randomized controlled trial conducted in a fee-for-service setting. Home Health Care Serv Q (2009) 1.72
Impact of distraction on the driving performance of adolescents with and without attention-deficit/hyperactivity disorder. JAMA Pediatr (2013) 1.63
A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders. Arch Pediatr Adolesc Med (2007) 1.62
A multisite, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of vigabatrin for treating cocaine dependence. JAMA Psychiatry (2013) 1.56
A genome-wide search for quantitative trait Loci that influence antisocial drug dependence in adolescence. Arch Gen Psychiatry (2005) 1.51
Inhalant use, abuse, and dependence among adolescent patients: commonly comorbid problems. J Am Acad Child Adolesc Psychiatry (2004) 1.43
Regional variation in mortality and subsequent hospitalization of nursing residents with heart failure. J Am Med Dir Assoc (2010) 1.41
Internet-delivered treatment for substance abuse: a multisite randomized controlled trial. Am J Psychiatry (2014) 1.40
A new tool for identifying discrepancies in postacute medications for community-dwelling older adults. Am J Geriatr Pharmacother (2004) 1.39
Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: an example from the NIDA Clinical Trials Network. Contemp Clin Trials (2011) 1.38
Validity of transdermal alcohol monitoring: fixed and self-regulated dosing. Alcohol Clin Exp Res (2006) 1.37
Predictors of self-reported HIV infection among drug injectors in Ukraine. J Acquir Immune Defic Syndr (2004) 1.35
Risky decisions and their consequences: neural processing by boys with Antisocial Substance Disorder. PLoS One (2010) 1.28
A practical tool to identify patients who may benefit from a palliative approach: the CARING criteria. J Pain Symptom Manage (2006) 1.25
A risk-taking "set" in a novel task among adolescents with serious conduct and substance problems. J Am Acad Child Adolesc Psychiatry (2006) 1.21
Multisite effectiveness trials of treatments for substance abuse and co-occurring problems: have we chosen the best designs? J Subst Abuse Treat (2010) 1.21
Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders. J Am Acad Child Adolesc Psychiatry (2011) 1.10
Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence. Drug Alcohol Depend (2008) 1.07
Using buprenorphine short-term taper to facilitate early treatment engagement. J Subst Abuse Treat (2006) 1.06
Predictors of risky needle use following interventions with injection drug users in Ukraine. Drug Alcohol Depend (2006) 1.04
Tobacco and alcohol use as an explanation for the association between externalizing behavior and illicit drug use among delinquent adolescents. Prev Sci (2004) 1.03
Physical activity in older, rural, Hispanic, and non-Hispanic white adults. Med Sci Sports Exerc (2005) 1.03
A randomized controlled trial of pemoline for attention-deficit/hyperactivity disorder in substance-abusing adolescents. J Am Acad Child Adolesc Psychiatry (2004) 1.03
The SRPHK1 outcome measure for cocaine-dependence trials combines self-report, urine benzoylecgonine levels, and the concordance between the two to determine a cocaine-use status for each study day. Drug Alcohol Depend (2007) 1.03
Randomized, controlled trial of atomoxetine for attention-deficit/hyperactivity disorder in adolescents with substance use disorder. J Am Acad Child Adolesc Psychiatry (2010) 1.03
Subjective effects, misuse, and adverse effects of osmotic-release methylphenidate treatment in adolescent substance abusers with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol (2011) 1.03
OROS-methylphenidate or placebo for adult smokers with attention deficit hyperactivity disorder: racial/ethnic differences. Drug Alcohol Depend (2010) 1.01
Cigarette and cannabis use trajectories among adolescents in treatment for attention-deficit/hyperactivity disorder and substance use disorders. Drug Alcohol Depend (2011) 1.00
Reducing HIV-related risk behaviors among injection drug users in residential detoxification. AIDS Behav (2011) 0.99
Elevated peri-transplant distress in caregivers of allogeneic blood or marrow transplant patients. Psychooncology (2013) 0.98
Gender research in the National Institute on Drug Abuse National Treatment Clinical Trials Network: a summary of findings. Am J Drug Alcohol Abuse (2011) 0.97
Using telehealth to provide diabetes care to patients in rural Montana: findings from the promoting realistic individual self-management program. Telemed J E Health (2011) 0.96
Attention-deficit/hyperactivity disorder (ADHD) symptoms, craving to smoke, and tobacco withdrawal symptoms in adult smokers with ADHD. Drug Alcohol Depend (2012) 0.95
Where do you want to spend your last days of life? Low concordance between preferred and actual site of death among hospitalized adults. J Hosp Med (2013) 0.95
Advance directive discussions: lost in translation or lost opportunities? J Palliat Med (2012) 0.95
Motivation Enhancement Therapy with pregnant substance-abusing women: does baseline motivation moderate efficacy? Drug Alcohol Depend (2008) 0.94
A genome-wide scan for loci influencing adolescent cannabis dependence symptoms: evidence for linkage on chromosomes 3 and 9. Drug Alcohol Depend (2006) 0.94
Reduced cortical gray matter volume in male adolescents with substance and conduct problems. Drug Alcohol Depend (2011) 0.93
An exploration of site effects in a multisite trial of OROS-methylphenidate for smokers with attention deficit/hyperactivity disorder. Am J Drug Alcohol Abuse (2011) 0.92
Conduct disorder and initiation of substance use: a prospective longitudinal study. J Am Acad Child Adolesc Psychiatry (2013) 0.91
A preliminary investigation of corpus callosum and anterior commissure aberrations in aggressive youth with bipolar disorders. J Child Adolesc Psychopharmacol (2012) 0.90
The CUIDAR Early Intervention Parent Training Program for Preschoolers at Risk for Behavioral Disorders: An Innovative Practice for Reducing Disparities in Access to Service. J Early Interv (2009) 0.90
An outreach intervention increases bone densitometry testing in older women. J Am Geriatr Soc (2009) 0.89
Telemedicine and the mini-mental state examination: assessment from a distance. Telemed J E Health (2009) 0.88
Divergence by ADHD subtype in smoking cessation response to OROS-methylphenidate. Nicotine Tob Res (2011) 0.88
Predictors of treatment response in adolescents with comorbid substance use disorder and attention-deficit/hyperactivity disorder. J Subst Abuse Treat (2012) 0.87
Tobacco dependence counseling in a randomized multisite clinical trial. Contemp Clin Trials (2012) 0.86
Integrated substance use and mental health treatment for adolescents: aligning organizational and financial incentives. J Child Adolesc Psychopharmacol (2005) 0.86
Adolescent inhalant use among male patients in treatment for substance and behavior problems: two-year outcome. Am J Drug Alcohol Abuse (2006) 0.86
Sex modulates approach systems and impulsivity in substance dependence. Drug Alcohol Depend (2013) 0.85
Negative reinforcement learning is affected in substance dependence. Drug Alcohol Depend (2011) 0.85
Attention-deficit/hyperactivity disorder subtypes in adolescents with comorbid substance-use disorder. Am J Drug Alcohol Abuse (2011) 0.84
A one-session human immunodeficiency virus risk-reduction intervention in adolescents with psychiatric and substance use disorders. J Am Acad Child Adolesc Psychiatry (2007) 0.84
Understanding and execution of discharge instructions. Am J Med Qual (2013) 0.83
Gender mix in twins and fetal growth, length of gestation and adult cancer risk. Paediatr Perinat Epidemiol (2005) 0.83
Separate and overlapping relationships of inattention and hyperactivity/impulsivity in children and adolescents with attention-deficit/hyperactivity disorder. Atten Defic Hyperact Disord (2012) 0.83
What came first, major depression or substance use disorder? Clinical characteristics and substance use comparing teens in a treatment cohort. Addict Behav (2005) 0.82
Incentives for retention of pregnant substance users: a secondary analysis. J Subst Abuse Treat (2009) 0.82
Family discord is associated with increased substance use for pregnant substance users. Subst Use Misuse (2013) 0.82
Toward prospective identification of high-risk surgical patients. Am Surg (2012) 0.82
A behavioral test of accepting benefits that cost others: associations with conduct problems and callous-unemotionality. PLoS One (2012) 0.82
Intraindividual Cortisol Variability and Psychological Functioning in Caregivers of Hematopoietic Stem Cell Transplant Patients. Psychosom Med (2016) 0.81
Neuroendocrine signaling via the serotonin transporter regulates clearance of apoptotic cells. J Biol Chem (2014) 0.81
Prescription drug abuse as a public health problem in Ohio: a case report. Public Health Nurs (2012) 0.81
Advances in neurobiological research related to interventions in adolescents with substance use disorders: research to practice. Drug Alcohol Depend (2007) 0.81
Characteristics of Northern Plains American Indians seeking substance abuse treatment in an urban, non-tribal clinic: a descriptive study. Community Ment Health J (2012) 0.80
External pressure, motivation, and treatment outcome among pregnant substance-using women. Drug Alcohol Depend (2009) 0.80
Deficient post-error slowing in children with ADHD is limited to the inattentive subtype. J Int Neuropsychol Soc (2012) 0.80
Increasing prenatal care and healthy behaviors in pregnant substance users. J Psychoactive Drugs (2010) 0.79
The relationship between ADHD symptom dimensions, clinical correlates, and functional impairments. J Dev Behav Pediatr (2013) 0.79
Improving treatment for opioid dependence: a perspective from the Ohio Valley node of the NIDA Clinical Trials Network. Prog Community Health Partnersh (2014) 0.79
Pre-treatment change in a randomized trial with pregnant substance-abusing women in community-based outpatient treatment. Contemp Clin Trials (2012) 0.79
Adolescent perspectives on the return of individual results in genomic addiction research. Psychiatr Genet (2015) 0.78
Risk of methylphenidate-induced prehypertension in normotensive adult smokers with attention deficit hyperactivity disorder. J Clin Hypertens (Greenwich) (2012) 0.78
A patient navigation intervention for drug-involved former prison inmates. Subst Abus (2014) 0.78
Optimal neurocognitive, personality and behavioral measures for assessing impulsivity in cocaine dependence. Am J Drug Alcohol Abuse (2014) 0.78
Advance directive discussions do not lead to death. J Am Geriatr Soc (2010) 0.78
Effect of integrated care on advanced chronic obstructive pulmonary disease in high-mortality rural areas. Arch Intern Med (2011) 0.78
Prevalence and predictors of injection drug use and risky sexual behaviors among adolescents in substance treatment. Am J Addict (2013) 0.77
Mediators of methylphenidate effects on math performance in children with attention-deficit hyperactivity disorder. J Dev Behav Pediatr (2014) 0.77
Relationship of age to impulsivity and decision making: a baseline secondary analysis of a behavioral treatment study in stimulant use disorders. J Addict Dis (2013) 0.77
"They're going to unplug grandma": advance directive discussions and documentation do not decrease survival in patients at baseline lower risk of death. J Hosp Med (2011) 0.77
Extended Visual Glances Away from the Roadway are Associated with ADHD- and Texting-Related Driving Performance Deficits in Adolescents. J Abnorm Child Psychol (2015) 0.77
Brain cortical thickness in male adolescents with serious substance use and conduct problems. Am J Drug Alcohol Abuse (2015) 0.76